A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the compared clinical efficacy of Lactase Eurofarma
(test drug), showing non-inferiority to Lactaid® (comparative drug) in the supportive
treatment of lactose intolerance and to assess the safety and tolerance of Lactase Eurofarma
(test drug) in the supportive treatment of lactose intolerance.